The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Clovis Oncology
Stock and Other Ownership Interests - Clovis Oncology
ARIEL4: An international, multicenter randomized phase 3 study of the PARP inhibitor rucaparib vs chemotherapy in germline or somatic BRCA1- or BRCA2-mutated, relapsed, high-grade ovarian carcinoma.
 
Amit M. Oza
Honoraria - WebRx
Consulting or Advisory Role - Amgen; Clovis Oncology; Immunovaccine; Verastem
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); Merck (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Domenica Lorusso
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; PharmaMar; Roche
Research Funding - PharmaMar (Inst)
Travel, Accommodations, Expenses - PharmaMar; Roche
 
Ana Oaknin
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; PharmaMar; Roche
 
Tamar Safra
No Relationships to Disclose
 
Elizabeth Swisher
No Relationships to Disclose
 
Igor Bondarenko
No Relationships to Disclose
 
Tomasz Huzarski
No Relationships to Disclose
 
Jaroslav Klat
No Relationships to Disclose
 
Róbert Póka
No Relationships to Disclose
 
Luciana Spillari Viola
No Relationships to Disclose
 
Chris Tankersley
Employment - Clovis Oncology; Sierra Oncology (I)
Stock and Other Ownership Interests - Clovis Oncology
 
Lara Maloney
No Relationships to Disclose
 
Sandra Goble
Employment - Clovis Oncology
Stock and Other Ownership Interests - Clovis Oncology
 
Caro Unger
Employment - Clovis Oncology; The Permante Medical Group (I)
Stock and Other Ownership Interests - Clovis Oncology; Sillajen
Travel, Accommodations, Expenses - The Permante Medical Group (I)
 
Heidi Giordano
Employment - Clovis Oncology
Stock and Other Ownership Interests - Clovis Oncology
 
Rebecca Sophie Kristeleit
Honoraria - AstraZeneca; Clovis Oncology; Roche/Genentech
Consulting or Advisory Role - Cerulean Pharma; Clovis Oncology; Lytix Biopharma; Medivation; Roche/Genentech; Sotio
Travel, Accommodations, Expenses - Basilea; Clovis Oncology; Valirx